+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pemirolast"

Eye Allergy Therapeutics Market Report 2025 - Product Thumbnail Image

Eye Allergy Therapeutics Market Report 2025

  • Report
  • October 2025
  • 250 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

Pemirolast is a type of anti-allergy drug used to treat allergic rhinitis, asthma, and other allergic conditions. It is a mast cell stabilizer, meaning it works by preventing the release of histamine and other substances from mast cells. Pemirolast is available in both oral and topical forms, and is often used in combination with other medications to treat allergies. It is generally well-tolerated, with few side effects. Pemirolast is used to treat a variety of allergic conditions, including hay fever, allergic rhinitis, asthma, and other allergic reactions. It is also used to treat hives and other skin reactions. It is available in both prescription and over-the-counter forms. The pemirolast market is highly competitive, with many companies offering different formulations of the drug. Some of the major players in the market include GlaxoSmithKline, Merck, Sanofi, and Novartis. Other companies include Allergan, Teva Pharmaceuticals, and Mylan. Show Less Read more